BRAIN CANCER

Latest News

AGuIX Gains FDA Fast Track Status in Malignant Gliomas and Glioblastoma
AGuIX Gains FDA Fast Track Status in Malignant Gliomas and Glioblastoma

May 31st 2024

The FDA has granted a fast track designation to AGuIX, a gadolinium-based nanodrug currently under evaluation for treating malignant gliomas and glioblastoma.

Brain Cancer Awareness Month: Challenges and Innovations in Treatment
Brain Cancer Awareness Month: Challenges and Innovations in Treatment

May 13th 2024

FDA Grants Accelerated Approval to Tovorafenib in Pediatric Low-Grade Glioma
FDA Grants Accelerated Approval to Tovorafenib in Pediatric Low-Grade Glioma

April 23rd 2024

Olaptesed Pegol Wins FDA Fast Track Designation in Brain Cancer
Olaptesed Pegol Wins FDA Fast Track Designation in Brain Cancer

April 3rd 2024

TTFields Increases Time to Progression in Patients With Brain Metastases From NSCLC
TTFields Increases Time to Progression in Patients With Brain Metastases From NSCLC

March 27th 2024

Latest CME Events & Activities

Oncology Consultations®: Next Generation SERDs—Key Data and Practical Takeaways for the Community Physician

View More

Medical Crossfire®: Leveraging Multidisciplinary Teams in Early–Stage Breast Cancer When the Goal is Cure

View More

Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!

View More

23rd Annual International Congress on the Future of Breast Cancer® East

July 19-20, 2024

Register Now!

Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer

View More

Community Practice Connections™: Controversies and Conversations About HER2- Expressing Breast Cancer…Advances in Management of HER2-Low to -Positive Disease

View More

Show Me the Data™: Do We Have Sea Change for Novel Approaches in HR+/HER2- Breast Cancer? CDK, PI3K/AKT, ADC, and Next-Gen SERD Strategies Assessed

View More

Cancer Summaries and Commentaries™: Clinical Updates from Chicago in Breast Cancer

View More

Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care

View More

Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes

View More

42nd Annual CFS®: Innovative Cancer Therapy for Tomorrow®

November 13-15, 2024

Register Now!

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

42nd Annual Miami Breast Cancer Conference®

March 6 - 9, 2025

Register Now!

The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…

View More

Coffee Talk™: Navigating the Impact of HER2/3, TROP2, and PARP from Early Stage to Advanced Breast Cancer Care

View More

More News